These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3508651)

  • 21. Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.
    Binkin NJ; Salmaso S; Tozzi AE; Scuderi G; Greco D; Greco D
    Pediatr Infect Dis J; 1992 Aug; 11(8):653-61. PubMed ID: 1523078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calculation of efficacy of acellular pertussis vaccine from the number of pertussis patients and vaccinees in three areas.
    Ohkuni H; Yabiku M; Togawa M; Fukai K; Yosida I; Minekawa Y; Kitamura T
    Dev Biol Stand; 1991; 73():43-9. PubMed ID: 1778332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a pertussis immunization program in a teaching hospital: an argument for federally mandated pertussis vaccination of health care workers.
    Calderon M; Feja KN; Ford P; Frenkel LD; Gram A; Spector D; Tolan RW
    Am J Infect Control; 2008 Aug; 36(6):392-8. PubMed ID: 18675144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of pertussis and high expectations concerning vaccines].
    Wysocki J
    Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].
    de Greeff SC; Schellekens JF; Mooi FR; de Melker HE
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Whooping cough--not eradicated, but forgotten].
    Swidsinski S; Schlesinger FL; Mebel S
    Z Arztl Fortbild (Jena); 1989; 83(6):309-12. PubMed ID: 2660433
    [No Abstract]   [Full Text] [Related]  

  • 29. Pertussis notifications in Australia, 1991 to 1997.
    Andrews R; Herceg A; Roberts C
    Commun Dis Intell; 1997 May; 21(11):145-8. PubMed ID: 9188218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    N Y State J Med; 1982 Oct; 82(11):1563-9. PubMed ID: 6959004
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pertussis: a reemerging infection?].
    Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diphtheria, tetanus, and pertussis: Guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee, Centers for Disease Control.
    Ann Intern Med; 1981 Dec; 95(6):723-8. PubMed ID: 6272621
    [No Abstract]   [Full Text] [Related]  

  • 34. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why pertussis immunisation?
    Tribe P
    Aust Fam Physician; 1989 Aug; 18(8):985-90. PubMed ID: 2673176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis in a rural area of Kenya: epidemiology and a preliminary report on a vaccine trial.
    Mahieu JM; Muller AS; Voorhoeve AM; Dikken H
    Bull World Health Organ; 1978; 56(5):773-80. PubMed ID: 310719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization.
    Kuno-Sakai H; Kimura M
    Pediatr Int; 2004 Dec; 46(6):650-5. PubMed ID: 15660862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization coverage increased in Suriname.
    Bull Pan Am Health Organ; 1985; 19(1):101-2. PubMed ID: 3875379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.
    McIntyre PB; Turnbull FM; Egan AM; Burgess MA; Wolter JM; Schuerman LM
    Vaccine; 2004 Dec; 23(3):380-5. PubMed ID: 15530684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.